Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Targeted Oncology|July 4, 2013
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecanFotios Loupakis, Chiara Cremolini, Anna Fioravanti, et al.
Oncology Reports|March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
Investigational New Drugs|February 9, 2021
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapyFrancesco Pasqualetti, Alessandra Gonnelli, Paola Orlandi, et al.
Genes|June 24, 2022
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-ChemotherapyFrancesco Pasqualetti, Celeste Giampietro, Nicola Montemurro, et al.
Angiogenesis|March 3, 2012
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancersGiacomo Allegrini, Teresa Di Desidero, Maria Teresa Barletta, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
American Journal of Clinical Oncology|May 22, 2018
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-OncologyFrancesco Pasqualetti, Andrea Pace, Alessandra Gonnelli, et al.
Clinical and Experimental Medicine|August 27, 2023
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE studyLuigi Coltelli, Chiara Finale, Gianna Musettini, et al.
Ecancermedicalscience|September 18, 2014
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, MilanGauthier Bouche, Nicolas André, Shripad Banavali, et al.
Pageof 16